Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison

被引:16
|
作者
Phillippo, David M. [1 ]
Dias, Sofia [1 ,2 ]
Ades, A. E. [1 ]
Welton, Nicky J. [1 ]
机构
[1] Univ Bristol, Bristol Med Sch Populat Hlth Sci, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England
[2] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England
基金
英国医学研究理事会;
关键词
effect modification; indirect comparison; individual patient data; matching-adjusted indirect comparison; population adjustment;
D O I
10.1002/jrsm.1416
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Indirect comparisons are used to obtain estimates of relative effectiveness between two treatments that have not been compared in the same randomized controlled trial, but have instead been compared against a common comparator in separate trials. Standard indirect comparisons use only aggregate data, under the assumption that there are no differences in effect-modifying variables between the trial populations. Population-adjusted indirect comparisons aim to relax this assumption by using individual patient data (IPD) from one trial to adjust for differences in effect modifiers between populations. At present, the most commonly used approach is matching-adjusted indirect comparison (MAIC), where weights are estimated that match the covariate distributions of the reweighted IPD to the aggregate trial. MAIC was originally proposed using the method of moments to estimate the weights, but more recently entropy balancing has been proposed as an alternative. Entropy balancing has an additional "optimality" property ensuring that the weights are as uniform as possible, reducing the standard error of the estimates. In this brief method note, we show that MAIC weights are mathematically identical whether estimated using entropy balancing or the method of moments. Importantly, this means that the standard MAIC (based on the method of moments) also enjoys the "optimality" property. Moreover, the additional flexibility of entropy balancing suggests several interesting avenues for further research, such as combining population adjustment via MAIC with adjustments for treatment switching or nonparametric covariate adjustment.
引用
收藏
页码:568 / 572
页数:5
相关论文
共 50 条
  • [41] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
    Armstrong, April W.
    Park, Sang Hee
    Patel, Vardhaman
    Hogan, Malcolm
    Wang, Wei-Jhih
    Davidson, David
    Chirikov, Viktor
    DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2589 - 2603
  • [42] Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison
    Swallow, Elyse
    Song, Jinlin
    Yuan, Yong
    Kalsekar, Anupama
    Kelley, Caroline
    Peeples, Miranda
    Mu, Fan
    Ackerman, Peter
    Signorovitch, James
    CLINICAL THERAPEUTICS, 2016, 38 (02) : 404 - 412
  • [43] Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Torres, Tiago
    Petersen, Anne Sohrt
    Ivens, Ulla
    Vilaro, Albert Bosch
    Stinson, John
    Carrascosa, Jose Manuel
    DERMATOLOGY AND THERAPY, 2024, 14 (04) : 983 - 992
  • [44] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Peter Nash
    Iain B. McInnes
    Philip J. Mease
    Howard Thom
    Matthias Hunger
    Andreas Karabis
    Kunal Gandhi
    Shephard Mpofu
    Steffen M. Jugl
    Rheumatology and Therapy, 2018, 5 : 99 - 122
  • [45] Matching-adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics
    Bourdin, Arnaud
    Husereau, Don
    Molinari, Nicolas
    Golam, Sarowar
    Siddiqui, Mohd Kashif
    Lindner, Leandro
    Xu, Xiao
    CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (04) : 442 - 452
  • [46] Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's Disease
    Dubinsky, Marla
    Ma, Christopher
    Griffith, Jenny
    Crowell, Marjorie
    Neimark, Ezequiel
    Kligys, Kristina
    O'Connell, Tom
    ADVANCES IN THERAPY, 2023, 40 (09) : 3896 - 3911
  • [47] Matching-adjusted indirect treatment comparison of onasemnogene abeparvovec and nusinersen for the treatment of symptomatic patients with spinal muscular atrophy type 1
    Bischof, Matthias
    Lorenzi, Maria
    Lee, Jennifer
    Druyts, Eric
    Balijepalli, Chakrapani
    Dabbous, Omar
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (10) : 1719 - 1730
  • [48] Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes MellitusA Matching-Adjusted Indirect Comparison of Randomized Trials
    James E. Signorovitch
    Eric Q. Wu
    Elyse Swallow
    Evan Kantor
    Liangyi Fan
    Jean-Bernard Gruenberger
    Clinical Drug Investigation, 2011, 31 : 665 - 674
  • [49] Comparative efficacy of combination immunotherapy and targeted therapy in the treatment of BRAF-mutant advanced melanoma: a matching-adjusted indirect comparison
    Atkins, Michael B.
    Tarhini, Ahmad
    Rael, Michael
    Gupte-Singh, Komal
    O'Brien, Elliott
    Ritchings, Corey
    Rao, Sumati
    McDermott, David F.
    IMMUNOTHERAPY, 2019, 11 (07) : 617 - 629
  • [50] A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma
    Mol, Isha
    Hu, Yannan
    Leblanc, Thomas W.
    Cappelleri, Joseph C.
    Chu, Haitao
    Nador, Guido
    Aydin, Didem
    Schepart, Alex
    Hlavacek, Patrick
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 660 - 668